In this journey, therapeutic nanoparticles selectively target tumors, enhance anticancer effectiveness and circumventing drug resistance 10, 11, 12.
To combat this issue, nanotechnology has emerged as a superior platform for the simultaneous delivery of drugs 6, 7, 8, 9. Hence, providing patients with effective drugs that minimize harmful effects is the need of the hour. As a result, low- and middle-income countries face several obstacles in cancer detection, diagnosis, and their related therapies 3, 4, 5.
Despite significant lab and clinical research, the prevalence of breast cancer continues to rise, inflicting misery on women 1, 2.
0 kommentar(er)
